Skip to main content
ADGM logo

ADGM · Adagio Medical Holdings, Inc. · Holdings

Track ADGM — free
$0.12 +0.00 (+0.67%) At close · Oct 20
Market Cap
$2.62M
Shares
22.21M
Volume · Oct 20 775.85K Avg daily vol (3M) 9.48M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
Holders: 24
Total Value: $9,818,670
Total Shares: 15,073,019

Institutional Ownership Trend

8 quarters

Holder Concentration

Across 24 13F filers · Δ vs Mar 31, 2026
Top Holder
65.6%
Sep 2024 → Jun 2026 · range 59.7% – 90.8%
+2.5 pts
Top 5
94.3%
Sep 2024 → Jun 2026 · range 89.1% – 98.3%
−0.2 pts
Top 10
98.7%
Sep 2024 → Jun 2026 · range 98.4% – 100.0%
−0.1 pts
HHI
4,521
Sep 2024 → Jun 2026 · range 3,799 – 8,266
Highly concentrated+291

Who Holds ADGM

Last 8 quarters through Jun 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026: 24 filers, like-for-like change -3.7%; actively managed books -4.0%; index-like books +13.5%.

Holder type Share Filers Change
Registered adviser 94.2% 12 -0.2%
Adviser 4.6% 1 -45.8%
Bank 0.6% 6 +37.3%
Holding company 0.0% 1 0.0%
Non-US 0.0% 0 —
Broker-dealer 0.0% 0 —
Unknown 0.6% 4 +16.1%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

24 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
0
0.000% of filers hold it in their top 10
Mar 31, 2026: 0
Holders above 5%
0
median weight 0.000%
Mar 31, 2026: 0
Crowding
66.4%
of shares outstanding, 100th percentile
Mar 31, 2026: 69.2%
Private-fund advisers
63.1%
of shares outstanding
Institutional ownership
67.9%
68.8% of the estimated free float
Top 10 holders
98.6%
of 13F shares, Herfindahl 0.451
Active holders
-4.0%
like-for-like share change of active filers
5% stakes on record
5
0 13D, 5 13G (3 institutional, 2 passive, 0 exempt)
How long holders have held it value-weighted 6.6 quarters
Under 1 year 23.5% 1 to 3 years 76.5% 3 years or more 0.000% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$3.58
estimated per share
Mar 31, 2026: $3.48
Quarter-end price
$0.65
implied by 13F values
Estimated gain or loss
-81.8%
price against the estimated cost
Estimated at a loss
100.0%
of costed 13F value

Estimated cost covers 98.8% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies ADGM's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 IBIO iBio, Inc. 3
2 RACC Research Alliance Corp III 3
3 CBIO Crescent Biopharma, Inc. 3
4 OVID Ovid Therapeutics Inc. 3
5 HLXC Helix Acquisition Corp. III 3
6 AVR Anteris Technologies Global Corp. 3
7 SION Sionna Therapeutics, Inc. 3
8 IMVT Immunovant, Inc. 3
9 ORKA Oruka Therapeutics, Inc. 4
10 SVRA Savara Inc 3

Shareholder Targets

13F filers that own its peers but not ADGM, quarter ended Jun 30, 2026

Found through its holder-overlap peers: IBIO, RACC, CBIO, OVID, HLXC, AVR, SION, IMVT, ORKA, SVRA, AVTX, PTGX, RYTM, CELC, TRVI, PRAX, SYRE, DNTH, COGT, QURE. 872 filers in all.

# Filer In peers
1 BlackRock, Inc. Holding company, Index-like $6,059,594,853 18 held
2 FMR LLC Holding company, Diversified active $6,007,266,368 18 held
3 STATE STREET CORP Bank, Index-like $2,817,153,603 18 held
4 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $2,357,617,036 7 held
5 Jupiter Topco LLC Unknown, Diversified active $2,182,006,864 15 held
6 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $2,126,041,119 17 held
7 RTW INVESTMENTS, LP Registered adviser, Diversified active $2,106,535,159 11 held
8 PRICE T ROWE ASSOCIATES INC /MD/ Registered adviser, Diversified active $1,865,164,247 17 held
9 RA CAPITAL MANAGEMENT, L.P. Registered adviser, Concentrated $1,413,470,440 7 held
10 WELLINGTON MANAGEMENT GROUP LLP Holding company, Diversified active $1,372,762,040 15 held

Fund Ownership of ADGM by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.86% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.37% 82,805
Index ETFs 0.49% 108,954
Active ETFs 0.00% 0
Active funds 0.00% 0
Unclassified 0.00% 0
All registered funds 0.86% 191,759
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Mar 31, 2026
New
4
Increased
5
Decreased
5
Sold Out
3
Unchanged
10

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +1
Institutional value: -45.5%
Shares held: -3.7%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 24 of 24
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 2006986 CUSIP 00534B100 Visit website Investor relations